IBDEI333 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,51724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51724,1,3,0)
 ;;=3^Abnormal Glucose
 ;;^UTILITY(U,$J,358.3,51724,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,51724,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,51725,0)
 ;;=R79.89^^227^2508^1
 ;;^UTILITY(U,$J,358.3,51725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51725,1,3,0)
 ;;=3^Abnormal Finding of Blood Chemistry
 ;;^UTILITY(U,$J,358.3,51725,1,4,0)
 ;;=4^R79.89
 ;;^UTILITY(U,$J,358.3,51725,2)
 ;;=^5019593
 ;;^UTILITY(U,$J,358.3,51726,0)
 ;;=R93.8^^227^2508^2
 ;;^UTILITY(U,$J,358.3,51726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51726,1,3,0)
 ;;=3^Abnormal Findings on Diagnostic Imaging
 ;;^UTILITY(U,$J,358.3,51726,1,4,0)
 ;;=4^R93.8
 ;;^UTILITY(U,$J,358.3,51726,2)
 ;;=^5019721
 ;;^UTILITY(U,$J,358.3,51727,0)
 ;;=R68.89^^227^2508^9
 ;;^UTILITY(U,$J,358.3,51727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51727,1,3,0)
 ;;=3^General Symptoms and Signs
 ;;^UTILITY(U,$J,358.3,51727,1,4,0)
 ;;=4^R68.89
 ;;^UTILITY(U,$J,358.3,51727,2)
 ;;=^5019557
 ;;^UTILITY(U,$J,358.3,51728,0)
 ;;=Z98.89^^227^2508^13
 ;;^UTILITY(U,$J,358.3,51728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51728,1,3,0)
 ;;=3^Postprocedural States
 ;;^UTILITY(U,$J,358.3,51728,1,4,0)
 ;;=4^Z98.89
 ;;^UTILITY(U,$J,358.3,51728,2)
 ;;=^5063754
 ;;^UTILITY(U,$J,358.3,51729,0)
 ;;=Z79.01^^227^2508^12
 ;;^UTILITY(U,$J,358.3,51729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51729,1,3,0)
 ;;=3^Long Term (Current) Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,51729,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,51729,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,51730,0)
 ;;=Z51.81^^227^2508^16
 ;;^UTILITY(U,$J,358.3,51730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51730,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,51730,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,51730,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,51731,0)
 ;;=Z63.4^^227^2508^5
 ;;^UTILITY(U,$J,358.3,51731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51731,1,3,0)
 ;;=3^Bereavement
 ;;^UTILITY(U,$J,358.3,51731,1,4,0)
 ;;=4^Z63.4
 ;;^UTILITY(U,$J,358.3,51731,2)
 ;;=^5063168
 ;;^UTILITY(U,$J,358.3,51732,0)
 ;;=Z71.89^^227^2508^6
 ;;^UTILITY(U,$J,358.3,51732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51732,1,3,0)
 ;;=3^Counseling,Specified
 ;;^UTILITY(U,$J,358.3,51732,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,51732,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,51733,0)
 ;;=Z76.0^^227^2508^11
 ;;^UTILITY(U,$J,358.3,51733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51733,1,3,0)
 ;;=3^Issue of Repeat Prescription
 ;;^UTILITY(U,$J,358.3,51733,1,4,0)
 ;;=4^Z76.0
 ;;^UTILITY(U,$J,358.3,51733,2)
 ;;=^5063297
 ;;^UTILITY(U,$J,358.3,51734,0)
 ;;=Z01.818^^227^2508^14
 ;;^UTILITY(U,$J,358.3,51734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51734,1,3,0)
 ;;=3^Preprocedural Examination
 ;;^UTILITY(U,$J,358.3,51734,1,4,0)
 ;;=4^Z01.818
 ;;^UTILITY(U,$J,358.3,51734,2)
 ;;=^5062628
 ;;^UTILITY(U,$J,358.3,51735,0)
 ;;=Z01.812^^227^2508^15
 ;;^UTILITY(U,$J,358.3,51735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51735,1,3,0)
 ;;=3^Preprocedural Lab Examination/Results
 ;;^UTILITY(U,$J,358.3,51735,1,4,0)
 ;;=4^Z01.812
 ;;^UTILITY(U,$J,358.3,51735,2)
 ;;=^5062627
 ;;^UTILITY(U,$J,358.3,51736,0)
 ;;=94640^^228^2509^1^^^^1
 ;;^UTILITY(U,$J,358.3,51736,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,51736,1,1,0)
 ;;=1^94640
 ;;^UTILITY(U,$J,358.3,51736,1,3,0)
 ;;=3^AEROSOL/NEB/MDI THERAPY
 ;;^UTILITY(U,$J,358.3,51737,0)
 ;;=31502^^228^2509^5^^^^1
 ;;^UTILITY(U,$J,358.3,51737,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,51737,1,1,0)
 ;;=1^31502
